Laser photocoagulation for neovascular age-related macular degeneration

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Virgili, Gianni ^a   Bini, A ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NONE

Author keywords

Choroidal neovascularization complications; *surgery ; Contrast sensitivity; Humans; Laser coagulation adverse effects; *methods ; Macular degeneration etiology; *surgery ; Treatment outcome; Visual acuity

Indexed keywords

ARGON LASER; CLINICAL TRIAL; COCHRANE LIBRARY; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EMBASE; FOLLOW UP; HUMAN; KRYPTON LASER; LASER COAGULATION; MEDLINE; META ANALYSIS; OBSERVATION; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; READING; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SCOTOMA; STATISTICAL ANALYSIS; SUBRETINAL NEOVASCULARIZATION; SYSTEMATIC REVIEW; VISUAL ACUITY;

EID: 44949135068     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004763.pub2     Document Type: Review

References (74)

1. Arnold 1997 {published data only} Arnold J, Algan M, Soubrane G, Coscas G, Barreau E. Indirect scatter laser photocoagulation to subfoveal choroidal neovascularization in age-related macular. Graefe's Archive For Clinical And Experimental Ophthalmology 1997;235(4):208- 16.
2. Bressler 1996 {published data only} Bressler NM, Maguire MG, Murphy PL, Alexander J, Margherio R, Schachat AP, et al.Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration: Results of a randomized pilot trial. Archives of Ophthalmology 1996;114(12):1456-64.
3. Canadian 1993 {published data only} * Canadian Ophthalmology Study Group. Argon green vs krypton red laser photocoagulation of extrafoveal choroidal neovascular lesions. One-year results in age-related macular degeneration. Archives of Ophthalmology 1993;111(2):177- 80.
4. Willan AR, Cruess AF, Ballantyne M. Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-years results of a multicentre randomized trial. Canadian Journal of Ophthalmology 1996;31(1):11-7.
5. Cardillo P. 1993 {published data only} Cardillo Piccolino FC, Ghiglione D, Allegri P. Grid laser treatment of occult choroidal neovascularization in age related macular degeneration. International Ophthalmology 1993;17(2):77-83.
6. Coscas 1983 {published and unpublished data} Coscas G, Soubrane G. Argon laser photocoagulation of macular subretinal neovascularization: Indications, methods, and results in 60 cases. Journal Francais d'Ophthalmologie 1984;7(2):99-105.
7. *Coscas G, Soubrane G. Argon laser photocoagulation of subretinal neovascularization in senile macular degeneration. Results of a randomized study of 60 cases. Bulletins et Memoires de la Societe Francaise d'Ophtalmologie 1982;94:149-54.
8. Soubrane G, Coscas G, Baudouin C, Koenig F. Randomized study of the photocoagulation with blue-green argon laser in subretinal neovascularization of senile macular degeneration. 5-year follow-up. Bulletin des Societes d'Ophtalmologie de France 1987;87(2):249-50.
9. Coscas 1991 {published data only} Coscas G, Soubrane G, Ramahefasolo C, Fardeau C. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration: Results of a randomized clinical trial. Archives of Ophthalmology 1991;109(9):1258-65.
10. Duch Mestres 1993 {published data only} Duch Mestres F, Vilaplana D, Civit JR, Torres F, Barraquer J. Static perimetry evaluation of argon green and dye red laser treatment for choroidal nevovascular membranes. Lasers and Light in Ophthalmology 1993;6(1):27-32.
11. Moorfields 1982 {published data only} The Moorfields Macular Study Group. Treatment of senile disciform macular degeneration: a single-blind randomised trial by argon laser photocoagulation. British Journal of Ophthalmology 1982;66(12):745-53.
12. MPS Argon Extra {published data only} Macular Photocoagulation Study Group. Argon Laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Archives of Ophthalmology 1991;109(8):1109-14.
13. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Archives of Ophthalmology 1986;104(5):694-701.
14. *Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Archive of Ophthalmology 1982;100(6):912-8.
15. Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Archives of Ophthalmology 1993;111(9):1189-99.
16. MPS Krypton Juxta {published and unpublished data} *Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Archives of Ophthalmology 1990;108(6):816-24.
17. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Archives of Ophthalmology 1994;112(4):500-9.
18. Macular Photocoagulation Study Group. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Archives of Ophthalmology 1996;114(4):400- 12.
19. MPS Subf. New {published and unpublished data} Macular Photocoagulation Study Group. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Archives of Ophthalmology 1994;112(9): 1176-84.
20. *Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Archives of Ophthalmology 1991;109(9): 1220-31.
21. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Archives of Ophthalmology 1993;111(9):1200-9.
22. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Archives of Ophthalmology 1994;112(4):489-99.
23. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Archives of Ophthalmoogy 1991;109(9):1242-57.
24. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Archives of Ophthalmology 1994;112(4):480- 8.
25. MPS Subf. Recurrent {published data only} Macular Photocoagulation Study Group. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Archives of Ophthalmology 1994;112(9): 1176-84.
26. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Archives of Ophthalmology 1993;111(9):1200-9.
27. *Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Archives of Ophthalmology 1991;109(9):1232-41.
28. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Archives of Ophthalmology 1994;112(4):489-99.
29. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Archives of Ophthalmoogy 1991;109(9):1242-57.
30. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Archives of Ophthalmology 1994;112(4):480- 8.
31. SST 2000 {published data only} Bressler NM, Bressler SB, Hawkins BS, Marsh MJ, Sternberg P Jr, Thomas MA. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. American Journal of Ophthalmology 2000;130(4):387-407.
32. Submacular Surgery Trials Research Groups. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: II. Quality of life outcomes submacular surgery trials pilot study report number 2. American Journal of Ophthalmology 2000;130(4):408-18.
33. Versteeg-Tijmes 1982 {published data only} Versteeg-Tijmes NT, de Jong PT, Bos PJ, Bakker D, Greve EL, Oosting J, et al.Argon laser treatment of pigment epithelial detachments and of subretinal neovascular membranes in Junius-Kuhnt's senile disciform macular degeneration. A prospective, randomized study. Graefe's Archive For Clinical & Experimental Ophthalmology 1982;218(5):271-4.
34. Yassur 1982 {published and unpublished data} Yassur Y, Axer-Siegel R, Cohen S, Svetliza E, Ben-Sira I. Treatment of neovascular senile maculopathy at the foveal capillary free zone with red krypton laser. Retina 1982;2(3):127-33.
35. Coscas 1983a Coscas G, Soubrane G. The effects of red krypton and argoon green laser on the foveal region. A clinical and experimental study. Ohthalmology 1983;90(8):1013-22.
36. AREDS 2001 Age-related Eye Disease Study Research Group. A randomised, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, Beta Carotene, and Zinc for age-related macular degeneration and vision loss. AREDS report No. 8. Archives of Ophthalmology 2001;119(10):1417-36.
37. Brown 2000 Brown GC, Brown MM, Sharma S, Brown H, Tasman W. Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization. Ophthalmology 2000;107(7):1374-80.
38. Brown 2006 Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al.Ranibizumab versus verteporfin for neovascular age-related macular degeneration. New England Journal of Medicine 2006;355(14):1432- 44.
39. Busbee 2003 Busbee BG, Brown MM, Brown GC, Sharma S. CME review: A cost-utility analysis of laser photocoagulation for extrafoveal choroidal neovascularization. Retina 2003;23(3):279-87.
40. Coscas 1983a Coscas G, Soubrane G. The effects of red krypton and argoon green laser on the foveal region. A clinical and experimental study. Ophthalmology 1983;90(8):1013-22.
41. D' Amico 2003 D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger S, Luna S, et al.Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy. Retina 2003;23(1):14-23.
42. EDPRG 2004 The Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States in the United States. Archives of Ophthalmology 2004;122(4):564-72.
43. Ergun 2003 Ergun E, Maar N, Radner W, Barbazetto I, Schmidt-Erfurth U, Stur M. Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 2003;110(1):65-9.
44. Eyetech 2002 Eyetech Study Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina 2002;22(2):143-52.
45. Ferris 1982 Ferris FL, Kassoff A, Bresnick G, Bailey I. New visual acuity charts for clinical research. American Journal of Ophthalmology 1982;94(1):91-6.
46. Fine 1986 Fine AM, Elman MJ, Ebert JE, Prestia PA, Starr JS, Fine SL. Earliest symptoms caused by neovascular membranes in the macula. Archives of Ophthalmology 1986;104(4):513-4.
47. Friedman 1999 Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsch JM. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology 1999;106(6):1049-55.
48. Fujii 2002 Fujii GY, Eong KG, Humayun MS, de Juan E Jr. Limited macular translocation: current concepts. Ophthalmology Clinics of North America 2002;15(4):425-36.
49. Glanville 2006 Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
50. Gragoudas 2004 Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. New England Journal of Medicine 2004;351(27):2805-16.
51. Gustavsson 2005 Gustavsson C, Agardh E. Transpupillary thermotherapy for occult subfoveal choroidal neovascularization: a 1-year, prospective randomized pilot study. Acta Ophthalmologica Scandinavica 2005;83(2):148-53.
52. Guyer 1996 Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Hanutsaha P, Spaide RF, et al.Classification of choroidal neovascularization by digital indocyanine green videoangiography. Ophthalmology 1996;103(12):2054-60.
53. Higgins 2006 Higgins JPT, Green S, editors. Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 6. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd.
54. IAE 1995 The International AMD Epidemiological Study Group. An international classification and Grading System for Age-related maculopathy and Age-related macular degeneration. Survey of Ophthalmology 1995;39(5):367-74.
55. Iwase 2006 Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, Kitazawa Y, et al.Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology 2006;113(8):1354-62.
56. Klein 1991 Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98(7):1128-34.
57. Klein 2006 Klein R, Klein BEK, Knudston MD, Wong TY, Cotch MF, Liu K, et al.Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006;113(3):373-80.
58. Lambert 2000 Lambert HM. The management of subfoveal choroidal neovascular membranes and hemorrhage. Seminars in Ophthalmology 2000;15(2):92-9.
59. Li 2006 Li Y, Xu L, Jonas JB, Yang H, Ma Y, Li J. Prevalence of age-related maculopathy in the adult population in China: the Beijing eye study. American Journal of Ophthalmology 2006;142(5):788-93.
60. Mangione 1998 Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, et al.Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Archives of Ophthalmology 1998;116(2):227-33.
61. Mangione 1999 Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of Age-related maculopathy on visual functioning and health-related quality of life. American Journal of Ophthalmology 1999;128(1):45-53.
62. McClure 2000 McClure ME, Hart PM, Jackson AJ, Stevenson MR, Chakravarthy U. Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?. British Journal of Ophthalmology 2000;84(3):244-50.
63. MPSG 1994 Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Archives of Ophthalmology 1994;112(4):480-8.
64. Rosenfeld 2006 Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al.Ranibizumab for neovascular age-related macular degeneration. New England Journal of Medicine 2006;355(14):1419- 31.
65. Sivagnanavel 2004 Sivagnanavel V, Evans JR, Ockrim Z, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2004, Issue 3.Art. No.: CD004004. DOI: 10.1002/14651858.CD004004.pub2.
66. Smith 2001 Smith W, Assink J, Kein R, Mitchell P, Klaver CCW, Klein BEK, et al.Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology 2001;108(4):697-704.
67. SST 2004a Hawkins BS, Bressler NM, Miskala PH, Bressler SB, Holekamp NM, Marsh MJ, et al.Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology 2004;111(11):1967-80.
68. SST 2004b Bressler NM, Bressler SB, Childs AL, Haller JA, Hawkins BS, Lewis H, et al.Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology 2004;111(11):1993-2006.
69. TAP 1999 TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. TAP Report 1. Archives of Ophthalmology 1999;117(10):1329-45.
70. TAP 2001 TAP Study Group. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration with Verteporfin: 2 Year Results of Two Randomized Clinical Trials-TAP report 2. Archives of Ophthalmology 2001;119(2):198-207.
71. Vander 2000 Vander JF. Macular translocation. Current Opinion in Ophthalmology 2000;11(3):159-65.
72. Verteporfin 2002 Verteporfin Roundtable. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 2002;22(1):6-18.
73. VIP 2001 Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in photodynamic therapy report 2. American Journal of Ophthalmology 2001;131(5):541-60.
74. Wormald 2003 Wormald R, Evans J, Smeeth L, Henshaw K. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2005, Issue 4.Art. No.: CD002030. DOI: 10.1002/14651858.CD002030.pub2.